Nothing here is for completeness. Each row changes an action.
Posted in two reports, 9/26 and 9/30; collected 09/22/2026 09:48, fasting ⟨DOC⟩. Full values are in the protocol file's Phenotype anchors. What each one changes:
🩸 Iron: Hgb 12.0 (9.9 on 8/10, 13.6 on 6/11) · MCV 78 (82 · 89) · RDW 17.2 (H) · ferritin 17 · TSAT 6% (Labcorp) / 4% (Esoterix, same draw) · sTfR 31.6 (H) · retic 0.6%. Hgb +2.1 is real; stores barely moved; the newest cells are the smallest — an iron-limited marrow on the eve of INFeD.
📐 Re-derived (open item 130): Ganzoni at Hgb 12.0 = 877 mg → the 1,000 mg covers 114% for the anemia. Aimed at the RLS ferritin of 100 it is ~1,040–1,210 mg → 83–96%. 🎯 Watch Hgb ≥ 12.5 on the recheck — in the one INFeD series in RLS with iron-deficiency anemia, no one who reached it was a non-responder ⟨C·9-30⟩.
🟠 Zinc 61 on 15 mg/day — in range on the report (44–115), below IZiNCG's 74 for a morning fasting male sample (open item 133). 🟠 ALP 127 → 124 → 139 — persistent, inside its ±20% noise band, far below the 2× stricture marker; GGT has never been run (open items 65, 134).
✅ Thyroid normal and antibody-negative (the first ever) · lipids excellent (ApoB 56 · Lp(a) 40.3 nmol/L — once-in-a-lifetime) · fructosamine 290 · C-peptide 1.8 (1.4 → 1.6 → 1.8 across the Frey) · B12 626 with MMA 124 · selenium 138 · vitamin E 7.3 = 4.97 µmol/mmol cholesterol, 2.2× the deficiency line · prealbumin 29 · serum copper 93 (105 on 6/11 — flat).
🔧 Corrected on documents: CA 19-9 has three points — 6/11 = 47, 8/10 = 52, same Roche assay — so the fall preceded surgery and post-op it is flat. Vitamin K1 resulted 0.30 on the 8/19 final. There is no 9/22 HbA1c; the clean one is 6.2 on 6/11, and it agrees with GMI 6.3 and fructosamine 290 (open item 135).
✅ Recheck — ORDERED at Labcorp ⟨N 10-01⟩, dated for the ≥4-week mark (~10/21; the exact date ⟨?⟩). Asked for: CBC · retic · iron/TIBC · ferritin, plus GGT · PTH · a repeat zinc — which of those made the order ⟨?⟩, one look at the requisition. A baseline DXA is imaging — a separate order. The message was follow-ups C4. Draw it like 9/22: morning, fasted, and say “INFeD 1,000 mg on 9/23.” 🆕 Water and prescriptions only until the needle is out — 🆕 the morning coffee waits — 8:30 from 10/29 (the 8:00 AM tea exited 10/10). 🆕 📝 Drafted as a request, not yet sent ⟨C·10-02⟩: a fasting total homocysteine on this draw — TMG 1 g/day has never been checked against one (follow-ups A9; tmg-indication).
⏳ Still to collect from the 9/22 order: stool for fecal elastase — keep taking Creon (Labcorp's assay does not read Pancreatin), formed stool, no urine in the vial, refrigerate if not dropped within 8 h — and urine for the ACR — random, ~10 mL, no hard exercise in the 24 h before, not with a fever or infection.
🆕 Drawn 9/22, the day before the IV iron, as this page required ⟨N 9-23⟩ — about 72 h iron-free. Results pending. 🆕 Resulted 9/26 and 9/30 — see the block above. When the report posts, correct the date from its own collection date. If nothing has posted by ~9/29, check three things: whether it is in Kuhlman's chart but not linked to your account, whether the order reached Labcorp, and whether the specimen was accepted. The paragraphs below are the history of how it got here.
🆕 The Kuhlman draw (L2605010156, 23 tests) is STILL PENDING as of 8/24 ⟨N 8-24⟩. Every rev since 7.44 wrote "~8/21". That was a forecast, not a document, and it did not happen. Nate's own framing: "in the next week or so, as I'm able" — coupled with the fecal elastase kit, one trip. There is no scheduled date and this page no longer prints one.
🆕 SCHEDULED — TUESDAY 9/22, MORNING ⟨N 9-21⟩, one day before the IV iron (Providence, Wed 9/23, 7:30 AM ⟨N 9-18⟩). The order this page needed holds: draw first. Prep: ① no iron — the 9/21 dose is the 48 h skip; ② water + prescriptions only until the needle is out — a lab fast is water only, and the 6:00–7:30 AM “fasted” slots carry ~6 g of free amino acids (5 g glutamine) against insulin, C-peptide and glucose on this panel; this corrects open item 52’s “fasted by default”; ③ usual water, not extra — sodium is one of the numbers; ④ the day before, swap out red meat or liver (same guideline, smaller effect). One exception offered to ②: the 6:30 AM L-theanine 100 if the Adderall is edgy without it. No biotin hold needed: Infini-B’s lot CoAs measure 30–37 µg per capsule. A forecast until the report exists — correct it from the report’s own collection date.
⚠️ This is the same failure class as the 8/7 → 8/10 correction, caught earlier. A forecast date carried across revs as though it were a fact. Surviving "~8/21" references elsewhere are historical forecasts, left as written — do not read them as scheduled, and do not bulk-replace them. 🔴 Everything gated on "after the ~8/21 draw" is now gated on "after the draw, date unset" — 🆕 the date is now set: 9/22 ⟨N 9-21⟩ — most consequentially the resveratrol cut, still queued and NOT executed ⟨N 8-24⟩, and the 48-hour iron skip before it.
🔴 And the panel now does two extra jobs it was not designed for: its glucose endpoints (fructosamine, insulin, HOMA-IR, C-peptide, HbA1c) will be an on-Cordyceps reading, and its CBC is now the substitute bleeding monitor for an antiplatelet-adjacent addition. See open items 69, 70.
Ferritin 10 (L) · Iron Saturation 4% — ALERT · Iron 16 (L) · TIBC 424 · UIBC 408 (H) · CRP 2 (normal) · Hgb 9.9 (L) (was 7.9 on 7/3) · Hct 32.3 (L) · MCV 82 · MCH 25.2 (L) · MCHC 30.7 (L) · RDW 14.4.
CRP normal is the finding that closes open item 3. This page spent four revs on the acute-phase trap — ferritin is an acute-phase reactant, Nate is ~8 weeks post-op, and Ret-He was named as the inflammation-independent test that was never ordered. With CRP at 2 there is nothing to adjust for. Ferritin 10 reads at face value. The ~8/21 sTfR, explicit TSAT and reticulocyte count are now confirmatory, not decisive — worth having as a paired series, but do not delay treatment for them.
Ganzoni deficit at 78.5 kg, Hgb 9.9: 78.5 × (14.0 − 9.9) × 2.4 = 772 mg, + 500 mg stores = ~1,272 mg. Oral at 36 mg elemental alternate-day closes that in roughly 8 months. One 1,000 mg ferric carboxymaltose infusion covers it in 15 minutes, and AASM gives IV FCM a strong recommendation at ferritin under 100 — this is 10, with TSAT 4%. ✅ CLOSED 8/27 — the route is IV and it went to KUHLMAN, not Wancata (open item 59). Referral placed for ferric derisomaltose (Monoferric), with ferric carboxymaltose specifically to be avoided. PHOSPHARE-IDA: hypophosphataemia 75.0% on FCM vs 7.9% on FDI, FGF23-driven and FCM-specific. ⚠ The AASM strong recommendation above is FCM's — do not read it as transferring to FDI (open item 80).
🆕 Given 9/23 ⟨N 9-23⟩: INFeD 1,000 mg, one total-dose infusion, one sitting, no premeds. That is 78.6% of the ~1,272 mg deficit above, before crediting oral iron absorbed 8/17–9/19 — 🆕 re-derived 9/30 at the 9/22 Hgb of 12.0: 877 mg → 114% for the anemia; ~83–96% for the RLS target (open item 130). The dose is Kuhlman's; whether a top-up follows is his call on the recheck.
🆕 🏷 What the infusion does to labs (INFeD label): serum iron is not meaningful for 3 weeks; ferritin peaks 7–9 days after the dose and eases back after about 3 weeks; bilirubin can read falsely high and calcium falsely low. At any draw or ER visit through ~10/21, say "INFeD 1,000 mg on 9/23." ✅ Recheck — ORDERED at Labcorp ⟨N 10-01⟩; the test list as ordered ⟨?⟩. Asked for: CBC · retic · iron + TIBC · TSAT · ferritin at ≥4 weeks (~10/21), Kuhlman (open item 130). 🆕 + GGT · PTH · repeat zinc asked for 9/30 — on the order or not ⟨?⟩; a DXA is a separate imaging order (follow-ups C4). 🩸 HbA1c is confounded to ~late December — 🆕 there is no 9/22 HbA1c (the order carried fructosamine, 290); CGM and fructosamine carry glycemia.
📌 Draw date corrected: every rev from 7.43 wrote 8/7. The Labcorp report reads Date collected: 08/10/2026 1113. 8/7 was the booking date, carried forward across five revs and never checked against a document. ⚠ HbA1c 5.6 is uninterpretable — post-transfusion pushes it down, iron deficiency pushes it up. CA 19-9 52, down from 73.6 on 1/20 — trajectory is the index. 🆕 A third point exists: 47 on 6/11 (same Roche assay) — the fall preceded surgery. Albumin 4.4, up from 3.0, confirms that was a bleed artifact.
| What | Changes what | |
|---|---|---|
| 02 | PT / INR from the 6/29–7/3 admission (a records pull, not a new draw) | If prolonged: EPI-mediated vitamin K deficiency contributed to the bleed. Structural, fixable, retires the antiplatelet conversation. |
| 03 | Iron — 🟢 SUBSTANTIALLY COVERED across both orders. ✅ 8/7: ferritin · Iron/TIBC · CRP · B12 · folate · CBC. ✅ ~8/21 adds Soluble Transferrin Receptor · Reticulocyte Count · explicit TSAT · Methylmalonic Acid plus repeats of all the 8/7 iron tests. ❌ Still not ordered: Ret-He (CHr) · peripheral smear — but sTfR against log-ferritin handles the acute-phase confound Ret-He was wanted for. | IV vs oral iron · R-ALA gate · masked mixed deficiency (MCV 91 is suspiciously normal in a bleeding, iron-deficient EPI patient) |
| 04 | Sodium: serum osm · urine osm · urine Na · urine urea · uric acid · 8 AM cortisol · TSH | SIADH vs hypovolemia vs reset osmostat vs adrenal insufficiency. Gates the ARB. |
| 05 | Free water intake — three days, logged | If the hyponatremia is dilutional, the intervention is fluid restriction, not more salt. |
| 06 | Dietary protein — three days, weighed | ESPEN post-major-surgery 1.5–2.0 g/kg/day → 118–157 g/day at 78.5 kg ⟨i: imported population, not a target adopted⟩. 🔴 Amino-9 and HMB were both CUT 8/14, so there is no supplemental buffer at all now. ❌ “Largest untouched lever” struck 8/3 — C-origin editorial ranking, never a finding. ⚠ Prior text computed this on the retired ~75 kg weight. |
| 07 | rs10830963 (MTNR1B) — AncestryDNA raw file | Melatonin 1 mg vs 3 mg. Free. Ten minutes. |
| Orthostatic vitals | Supine → 1 min → 3 min standing | Volume status. The one finding you cannot self-generate. Critical before any ARB change. |
| 24-hour ABPM | Ambulatory monitor | Characterises the postprandial pattern. 🆕 Was “must precede any berberine restart” — overtaken: berberine has run since ~8/1 ⟨N 9-15⟩. Still wanted for the BP endpoint; no longer a gate. |
| Supervised oral water load | Nephrology | Only if the panel points to the SIADH family. >80% excreted in 4 h = reset osmostat. <80% = SIADH. Not a home experiment. |
Rebuilt 8/14 from Wancata’s signed order set, 7/29/2026 — 22 orders, IDs 5033178020–041, contiguous, no gaps, all dx K86.1, all Release to patient: Immediate. 🔵 Updated 8/14: a SECOND order exists — Kuhlman, Labcorp L2605010156, 23 tests, draw ~8/21, not yet done. It closes six of the eight gaps below. 11 tests sit on both orders, which makes a paired ~2-week series rather than duplication waste. Results route to the ordering provider: 8/7 → Wancata (206-341-0060); ~8/21 → Kuhlman via Labcorp. ✅ Kuhlman is the PCP ⟨N✓8-17⟩ and holds 23 pending tests — results route to him and that is correct routing, not a collision. The "sequence the transition around that" warning is STRUCK: he has not been replaced. See pcp-vacancy.
| ✅ ORDERED (22) | CBC w/ diff · CMP (fasted) · Magnesium · Phosphorus · HbA1c · CA 19-9 · C-Peptide · Lipase · B12 · Folate ×2 · Vitamin A · D 25-OH · E · K · TSH · Pancreatic Elastase Fecal · Copper · Ceruloplasmin · Iron and TIBC · Ferritin · CRP |
⚠ Advanced Lipid 260267 — Kuhlman | 🔵 ORDERED after all, on the ~8/21 draw. |
✅ Albumin/Creatinine Ratio, Urine 140285 — Kuhlman | 🔵 CLOSED 8/14 — it IS being measured, on the ~8/21 draw. The only remaining axis that could justify telmisartan 80 gets its reading. The BP re-baseline quoted here (120.8/66.5) is itself superseded: current protocol-correct mornings run 119.5–133.5 systolic, 28-day mean 126/66. |
✅ Prealbumin 016931 · ✅ Zinc 001800 — Kuhlman | 🔵 BOTH CLOSED 8/14 on the ~8/21 draw. Zn:Cu is answerable. 🆕 9/22: zinc 61 — low against IZiNCG's 74 (open item 133); prealbumin 29. ⚠ But there is no PRE-CUT prealbumin and there cannot be — both EAA sources came out 8/14, prealbumin has a ~2-day half-life, and the draw is a week later. It reads post-cut status, not a before-and-after. |
| Serum copper + ceruloplasmin new 7.19 | Copper is the DAO metal cofactor and currently unmeasured. ⚠ Ceruloplasmin is acute-phase — read only against the CRP already on this panel, same trap as ferritin, or the number is uninterpretable. |
| ✅ 25-OH-D · Ca (on CMP) | 🆕 D3 total is now 7,000 IU — the ~1,000 IU HMB bundle left with the 8/14 cut. ⚠ This draw was taken with the bundle still on board (~8,000 IU D3, ~398 mg supplemental Ca), so it is an on-HMB reading and will not compare to anything measured after 8/14. |
| ✅ Vitamin A · E · K | 🆕 Fat-soluble panel — appropriate for exocrine insufficiency and absent from this hub until 8/14. All on-supplement readings (Vit E 200 IU, K2 180 µg/day). Vitamin K is the pending half of the bleed question in row 02. 🆕 K1 resulted: 0.30 on the 8/19 final. 9/22: A 46.6 · E 7.3 (4.97 µmol/mmol cholesterol). |
| ✅ Pancreatic Elastase Fecal | 🔴 The only direct measure of exocrine function in the set — the one test that speaks to Creon dosing. It is a STOOL test. If 8/7 was phlebotomy only, it may never have been collected. 🆕 Still uncollected 9/30 ⟨N⟩. Labcorp: keep taking Creon — the assay does not read Pancreatin. |
✅ Fructosamine 100800 — Kuhlman | 🔵 CLOSED 8/14 on the ~8/21 draw. The instrument this hub called the only trustworthy glycemic read until the CGM is validated. HbA1c (Wancata, 8/7) still carries its transfusion caveat below. 🆕 9/22: 290 (0–285). |
✅ C-Peptide (both) · ✅ Insulin 004333 — Kuhlman | 🔵 CLOSED 8/14 — HOMA-IR is computable from the ~8/21 insulin + CMP glucose. The agmatine/gymnema hold had a real endpoint after all. ⚠ C-peptide is on both orders, so you get it twice, two weeks apart — which is better than the single fasting value this hub warned against adjudicating on. 🆕 9/22: C-peptide 1.8 (1.4 on 6/11, 1.6 on 8/10) · insulin 6.4 · HOMA-IR ≈ 1.9. |
| HbA1c — 🆕 ORDERED ANYWAY | drawn ~5 wks post-transfusion | ⚠ The deferral reason still holds: falsely low this soon after 2u RBC. The result is coming and should not be read as a clean glycemic index. 🆕 It came: 5.6 (8/10). The clean one is 6.2 on 6/11, pre-op; none was drawn 9/22. |
| CA 19-9 — 🆕 ORDERED ANYWAY | drawn ~6 wks post-Frey | ⚠ Prior 73.6 (H), 1/20/2026; 6/18 pathology benign. CA 19-9 has poor specificity in chronic pancreatitis and biliary disease — an elevated value is not by itself a cancer finding. A trajectory is the index, not a single value. Interpretation is Wancata’s. CEA was not ordered. 🆕 6/11 carried CA 19-9 47 and CEA 4.0 (in range) — three CA 19-9 points: 73.6 → 47 → 52. |
📌 8/3 — retired, argument and all. Its own reconciliation line always said it: the team attributed the ulcers to non-specific post-op change and ran no etiology hunt — a low-cost hedge, not a live alarm. The header calling it "the load-bearing unknown" is what propagated, into the MegaSpore gate, a PPI-washout item, a mastic-gum flag, and an 8/3 NAC "test confound" that is now retracted. No positive finding ever existed. Nothing waits on this.
Ferritin is an acute-phase reactant and you are ~4 weeks post-major surgery. Ret-He / CHr is the test — inflammation-independent, reports iron incorporated into hemoglobin over 48 hours. ⚠ It was not ordered on either draw — but Kuhlman ordered Soluble Transferrin Receptor, the other inflammation-independent marker, with the larger validation literature. sTfR against log-ferritin is the established way to separate true iron deficiency from anemia of chronic disease. 🛑 No add-on call is needed. If IV iron is indicated, ask for ferric derisomaltose (Monoferric) by name — not ferric carboxymaltose (formulation-specific hypophosphatemia). 🆕 Settled 9/23: INFeD 1,000 mg was given as one total-dose infusion — the route question is closed.